Visit Invicro inside the REALM IDx Booth #3117 to speak with imaging experts and learn how our clinical expertise can help transform your cancer drug discovery and development.

Visit us at ASCO


Oral Abstract Session 
Presenter: Andrew Armstrong, M.D. | Professor of Medicine, Duke University School of Medicine 
Genitourinary Cancer | Hall D2 | Abstract #5002 
Sunday, June 5, 8:24 AM CDT 

[68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in pts with mCRPC: a VISION sub-study 

Invicro co-authors:
Phillip Kuo M.D., Ph.D. | Senior Medical Director
Jacob Hesterman Ph.D. | Distinguished Scientist

Your Full-Service Imaging CRO

Invicro uniquely combines operational, scientific and medical expertise to support your cancer drug discovery and development pipelines.
*Click titles below to learn more.*

Radiopharmaceutical Therapy

Complete solutions for streamlined development, evaluation and clinical translation of radiopharmaceuticals

Clinical Imaging Core Lab

Advanced scientific, medical and operational expertise to deliver global studies from Phase I-IV


Research Imaging Services

Molecular imaging solutions spanning from preclinical through late-phase clinical to support drug discovery and development 

Advanced Pathology Services

Custom biomarker assay validation, development and AI-powered image analysis services to gain spatial tissue insights


Primary method development for transfer from sponsor to label candidates, including biologics, small molecules, cells and more 

Image Analytics

Qualitative and quantitative image analytics for radiology and pathology studies, utilizing machine learning and artificial intelligence



View Oncology Solutions